Sierk Poetting
Chief Operating Officer bij BIONTECH SE
Vermogen: 68 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Sierk Poetting
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
33
| Public Company | Pharmaceuticals: Major | 33 |
18
| Public Company | Biotechnology | 18 |
IQM Finland Oy
 IQM Finland Oy Information Technology ServicesTechnology Services IQM Finland Oy operates as a quantum computing company. It engages in building hardware for quantum computers that focuses on superconducting technology. The company was founded by Juha Johannes Vartiainen, Kuan Yen Tan, Jan Goetz, and Mikko Pentti Matias M?tt?nen and is headquartered in Espoo, Finland.
10
| Holding Company | Information Technology Services | 10 |
JPT Peptide Technologies GmbH
 JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology JPT Peptide Technologies GmbH provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery. The firm’s products include custom peptides, modified & labeled peptides, clinical peptides, stable isotope-labeled peptides, SPOT peptides, immunogenic peptides, peptide libraries, peptide pools, peptide microarrays, peptide ELISA, enzyme profiling and epitope discovery service. The company was founded in 2004 and is headquartered in Berlin, Germany.
2
| Subsidiary | Medical Specialties | 2 |
BioNTech Delivery Technologies GmbH
 BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The private company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sierk Poetting via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman Compliance Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| OPTINOSE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Director of Finance/CFO | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Chairman Chief Executive Officer | |
| University of California, Berkeley | College/University | Graduate Degree Graduate Degree | |
| University of Maryland | College/University | Graduate Degree Doctorate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chairman Chairman Public Communications Contact | |
| Universität des Saarlandes | College/University | Doctorate Degree Undergraduate Degree | |
| University of Basel | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Zurich | College/University | Director/Board Member Undergraduate Degree | |
Vanguard AG
 Vanguard AG Miscellaneous Commercial ServicesCommercial Services Vanguard AG engages in the development, manufacture, and sale of medical devices and equipment used for cardiology and endoscopy. The company was founded by Bernard Frieling and Robert Schrödel in 1998 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Undergraduate Degree | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
MIG Verwaltungs AG
 MIG Verwaltungs AG Investment ManagersFinance MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved. | Investment Managers | Founder Private Equity Investor | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
AFFiRiS AG
 AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member | |
APK AG
 APK AG Wholesale DistributorsDistribution Services APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany. | Wholesale Distributors | Director/Board Member Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Public Communications Contact Corporate Officer/Principal | |
Global Health Council, Inc.
 Global Health Council, Inc. Miscellaneous Commercial ServicesCommercial Services Global Health Council, Inc. is a leading member organization that advocates for global health priorities by uniting advocates, implementers, policy makers, and other stakeholders. The non-profit company is based in Washington. The American company works across health sectors to achieve the greatest impact and provides access to information, resources, and expertise. The company elevates critical health messages by aggregating, aligning, and promoting the work of members and advocates. | Miscellaneous Commercial Services | Director/Board Member | |
US Pharmaceuticals, Inc.
 US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology US Pharmaceuticals, Inc. manufactures and distributes medicines. The private company is based in Seal Beach, CA. | Pharmaceuticals: Major | Public Communications Contact | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
AT Newtec GmbH
 AT Newtec GmbH Financial ConglomeratesFinance AT Newtec GmbH provides investment and management services. The firm’s investment operations focus on businesses engaged in the biotechnology research and development sector. The company was founded by Andreas Strungmann and Thomas Strungmann is headquartered in Munich, Germany. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Novartis Pharma BV | Chairman Corporate Officer/Principal | ||
| LucerneHealth | Chief Tech/Sci/R&D Officer | ||
| Association For Cancer Immunotherapy | President Chairman | ||
| New York University School of Law | College/University | Graduate Degree | |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| CARDAX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Ci3 Management UG | Chairman Founder Director/Board Member | ||
| RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
TRON - Translationale Onkologie an der Universitätsmedizin der
 TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Chief Executive Officer Director/Board Member | |
Stupid Cancer
 Stupid Cancer Miscellaneous Commercial ServicesCommercial Services Stupid Cancer is an organization that helps to empower everyone affected by adolescent and young adult (AYA) cancer by ending isolation and building community. Stupid Cancer is based in New York. The American company offers various programs designed to connect AYAs with others who understand their experiences. | Miscellaneous Commercial Services | Director/Board Member | |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Global Oncology, Inc. | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 26 |
| Duitsland | 14 |
| Zwitserland | 6 |
| Verenigd Koninkrijk | 4 |
| Ierland | 2 |
Sectoraal
| Health Technology | 21 |
| Commercial Services | 11 |
| Consumer Services | 10 |
| Finance | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 180 |
| Corporate Officer/Principal | 140 |
| Chief Executive Officer | 69 |
| Chairman | 60 |
| Independent Dir/Board Member | 41 |
Sterkste connecties
| Insiders | |
|---|---|
| Helmut Jeggle | 47 |
| Ulrich Wandschneider | 25 |
| Daniel Vasella | 25 |
| Pablo Cagnoni | 24 |
| Jonathan Symonds | 24 |
| Bill Winters | 21 |
| Hans Jörg Reinhardt | 20 |
| Charles Sawyers | 16 |
| Sean Marett | 15 |
| Michele Galen | 15 |
| Eric Cornut | 14 |
| Kim Stratton | 14 |
| Jens Holstein | 14 |
| Sotirios G. Stergiopoulos | 13 |
| Daria Saharova | 13 |
- Beurs
- Insiders
- Sierk Poetting
- Bedrijfsconnecties
